Xenon Pharmaceuticals Inc. reports

Company location: Burnaby
Fiscal year end: 31 December

Xenon Pharmaceuticals Inc. has filed 796 SEC EDGAR filings since 16 Aug 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 796 matching filings.

Per page

25

Current page

9

4

4

Filing date: 02 Jun 2023
Reporting date: 02 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 02 Jun 2023
Reporting date: 02 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 02 Jun 2023
Reporting date: 02 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36687

8-K

Filing date: 02 Jun 2023
Reporting date: 01 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 01 Jun 2023
Reporting date: 30 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36687

144 filing

Filing date: 01 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36687

144 filing

Filing date: 31 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36687

144 filing

Filing date: 30 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 26 May 2023
Reporting date: 24 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 001-36687

144 filing

Filing date: 24 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36687

10-Q

Filing date: 09 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36687

8-K

Filing date: 09 May 2023
Reporting date: 09 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-36687

ARS

Filing date: 27 Apr 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36687

DEF 14A

Filing date: 27 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Mar 2023
Reporting date: 24 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36687

8-K

Filing date: 14 Mar 2023
Reporting date: 10 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 09 Mar 2023
Reporting date: 07 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36687

8-K

Filing date: 08 Mar 2023
Reporting date: 08 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .